FCGRT and diabetes mellitus: In conclusion, the efficacy of oral PPI-Fc treatment in terms of systemic and thymic antigen delivery via the intestinal FcRn pathway warrants further investigations to develop antigen formulations and/or regimens that can translate into diabetes prevention.